# US 2022/0016022 A1 · Anterior chamber perfusate for intraocular surgery and method

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0016022 A1
- Document ID: US20220016022A1
- Status: Published application
- Kind: A1
- Application number: 17/461,086
- Filed: 2021-08-30
- Published: 2022-01-20
- Earliest claimed: 2019-02-28
- Assignees: Xiamen University
- Applicants: Xiamen University
- Inventors: Cheng LI; Mengyi JIN; Ying HONG; Zuguo LIU
- Web page: https://patentgrep.com/patent/US20220016022A1

## CPC

- A61K 9/0048: {Eye, e.g. artificial tears}
- A61F 9/007: Methods or devices for eye surgery
- A61K 9/08: Solutions {(composition of solutions A61K47/00)}
- A61K 31/198: Alpha-amino acids, e.g. alanine or edetic acid [EDTA] (betaine A61K31/205; proline A61K31/401; tryptophan A61K31/405; histidine A61K31/4172; peptides not degraded to individual amino acids A61K38/00)
- A61K 47/02: Inorganic compounds
- A61K 47/12: Carboxylic acids; Salts or anhydrides thereof
- A61P 41/00: Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
- A61B 2217/007: with irrigation system
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

An anterior chamber perfusate for intraocular surgery and its use. The anterior chamber perfusate not only balances intraocular pressure, but also contains a certain amount of L-alanyl-L-glutamine (Ala-Gln).

## Claims

### Claim 1

An anterior chamber perfusate for intraocular surgery, wherein the anterior chamber perfusate is an ophthalmic balanced salt solution comprising 0.217-1.090 mg/mL L-alanyl-L-glutamine.

### Claim 2 (depends on 1)

The anterior chamber perfusate for intraocular surgery according to claim 1, wherein the ophthalmic balanced salt solution comprises 1.085-1.087 mg/mL of L-alanyl-L-glutamine.

### Claim 3 (depends on 1)

The anterior chamber perfusate for intraocular surgery according to claim 1, wherein the ophthalmic balanced salt solution comprises 5.95-6.00 mg/mL sodium chloride, 0.29-0.30 mg/mL potassium chloride, 0.19-0.20 mg/mL calcium chloride, and 3.05-3.15 mg/mL sodium lactate.

### Claim 4 (depends on 2)

The anterior chamber perfusate for intraocular surgery according to claim 2, wherein the ophthalmic balanced salt solution comprises 5.95-6.00 mg/mL sodium chloride, 0.29-0.30 mg/mL potassium chloride, 0.19-0.20 mg/mL calcium chloride, and 3.05-3.15 mg/mL sodium lactate.

### Claim 5 (depends on 1)

A method for applying the anterior chamber perfusate for intraocular surgery according to claim 1.

### Claim 6 (depends on 2)

A method for applying the anterior chamber perfusate for intraocular surgery according to claim 2.

### Claim 7 (depends on 3)

A method for applying the anterior chamber perfusate for intraocular surgery according to claim 3.

### Claim 8 (depends on 4)

A method for applying the anterior chamber perfusate for intraocular surgery according to claim 4.
